Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01269671

Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Medical College of Wisconsin · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Not accepted

Summary

IND application was submitted to FDA on November 17th.

Conditions

Interventions

TypeNameDescription
DRUGMelatonin, Peppermint Oil (mentharil), and SimethiconeDosing will be dependent on patient's age during time of enrollment. Patients 8-12 years of age will receive Melatonin 3mg tab at night, Peppermint oil 1 capsule (0.2ml) 30-60 minutes prior to meal twice daily, and Simethicone 80mg tab 30-60 minutes prior to meal twice daily. Patients 13-18 years of age will receive Melatonin 3mg tab at night, Peppermint oil 2 capsules (0.4ml) 30-60 minutes prior to meal twice daily, and Simethicone tab 125mg 30-60 minutes prior to meal twice daily
OTHERSugar pillPatients in the placebo group will receive one placebo tab to be taken at night, one placebo capsule to be taken 30-60 minutes prior to meal twice daily, and one placebo tab to be taken 30-60 minutes prior to meal twice daily.

Timeline

Start date
2011-01-01
Primary completion
2012-01-01
Completion
2012-04-01
First posted
2011-01-04
Last updated
2015-08-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01269671. Inclusion in this directory is not an endorsement.